The first generic versions of the antidepressant drug Cymbalta (duloxetine delayed-release capsules) have been approved by the U.S. Food and Drug Administration. License to produce generic Cymbalta was granted to Aurobindo Pharma Ltd., ...
Tags: antidepressant drug, Cymbalta, duloxetine delayed-release capsules
The U.S. Food and Drug Administration approved the first generic versions of Cymbalta, a drug used to treat depression and other conditions, officials say. Dr. Kathleen Uhl, acting director of the Office of Generic Drugs in the FDA's ...
Aurobindo Pharma has gained final FDA approval for its generic Nevirapine tablets and oral suspension used for treating human immunodeficiency virus (HIV). The FDA approved Nevirapine tablets of 200mg strength and Nevirapine oral ...
Tags: Aurobindo Pharma, FDA, Nevirapine, HIV drug
The USFDA has issued final approval to manufacture and market Aurobindo Pharma's diabetes drugs, Pioglitazone tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride tablets. Pioglitazone Tablets USP 15mg, 30mg & 45mg and ...
Tags: USFDA, Aurobindo Pharma, diabetes drugs
Aurobindo Pharma has secured approval from the US FDA to manufacture and market nafcillin for injection USP, packed in 1g and 2g bottles as well as nafcillin for injection USP 10g bottle pharmacy bulk package. Nafcillin, is a sterile ...
Tags: Aurobindo Pharma, market nafcillin, injection USP, pharmacy bulk package
Aurobindo Pharma has won the final FDA approval to manufacture and market its generic anti-Human Immunodeficiency Virus (HIV) drug, Abacavir Tablets USP 300mg. Abacavir, the generic version of ViiV Healthcare Company's Ziagen Tablets ...
Tags: Anti-HIV Drug, FDA Nod, Aurobindo, Medicine
India-based Aurobindo Pharma has named Arvind Vasudeva as the company's new chief executive officer (CEO) of the formulations division. Previously, Vasudeva served at Glenmark Pharmaceuticals as chief operating officer, as well as RPG ...
Tags: formulations division, Life Sciences, biotechnology company
Pharmaceutical business re-engineering solutions provider Goose Technologies has launched Goose Proofreader, a 21 CFR part 11 compliant solution that enables review of printed materials. Glenmark Pharmaceuticals and Aurobindo Pharma have ...